Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients.

Oncotarget - 4 Oct 2016

Wang Yuhan, Han Yingying, Weng Qiang, Yuan Zhengrong

Abstract excerpt

The Xeroderma pigmentosum complementation group G (XPG) rs2296147T>C polymorphism is suspected to associate with the clinical outcomes of cancer patients. However, the results are inconsistent. This meta-analysis aimed to evaluate the reliable predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients. A total of 11 eligible studies were enrolled in this meta-analysis. Our results...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Case-Control Studies
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Neoplasms

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Xeroderma Pigmentosum Group D Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 27588464
DOI: 10.18632/oncotarget.11664
PMCID: PMC5323191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients.PMID 27588464Read ↗

Comprehensive assessment of the association between XPC rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls.Semantic proximity Read ↗

XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer.Semantic proximity Read ↗

XPG gene polymorphisms and cancer susceptibility: evidence from 47 studies.Semantic proximity Read ↗

Association between the polymorphisms in XPG gene and gastric cancer susceptibility in Chinese populations: A PRISMA-compliant meta-analysis.Semantic proximity Read ↗

The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies.Semantic proximity Read ↗

Contribution of xeroderma pigmentosum complementation group D gene polymorphisms in breast and ovarian cancer susceptibility: A protocol for systematic review and meta analysis.Semantic proximity Read ↗

Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.Semantic proximity Read ↗

Relationship between ERCC1 and XPC polymorphisms and the susceptibility to head and neck carcinoma: A systematic review, meta-analysis, and trial sequential analysis.Semantic proximity Read ↗

XPG is predictive gene of clinical outcome in advanced non-small-cell lung cancer with platinum drug therapy.Semantic proximity Read ↗

Association of XPG gene rs751402 polymorphism with gastric cancer risk: a meta-analysis in the Chinese population.Semantic proximity Read ↗

Association between XPF polymorphisms and cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.